Related references
Note: Only part of the references are listed.Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease
Stephen Mullin et al.
MOVEMENT DISORDERS (2021)
Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2
Ria Thomas et al.
MOLECULAR BRAIN (2021)
Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease
Marco Toffoli et al.
MOVEMENT DISORDERS (2021)
Experience in Genetic Counseling for GBA1 Variants in Parkinson's Disease
Jonas M. den Heijer et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2021)
The genetic architecture of Parkinson's disease
Cornelis Blauwendraat et al.
LANCET NEUROLOGY (2020)
Parkinson disease
R. Balestrino et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes
Giulia Massaro et al.
HUMAN MOLECULAR GENETICS (2020)
Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease
Susanne A. Schneider et al.
JOURNAL OF NEUROLOGY (2020)
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease (vol 14, 40, 2019)
Mylene Huebecker et al.
MOLECULAR NEURODEGENERATION (2020)
Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult
Michael X. Henderson et al.
NEURON (2020)
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations A Nonrandomized, Noncontrolled Trial
Stephen Mullin et al.
JAMA NEUROLOGY (2020)
Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson Disease
Elisa Menozzi et al.
CNS DRUGS (2020)
Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: a Kin Cohort Study
Roberta Balestrino et al.
MOVEMENT DISORDERS (2020)
The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects
Yoo-Mi Kim et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations
Hongyu Li et al.
AUTOPHAGY (2019)
Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation
M. Judith Peterschmitt et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Emerging links between pediatric lysosomal storage diseases and adult parkinsonism
Daniel Ysselstein et al.
MOVEMENT DISORDERS (2019)
Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
Marie Therese Fuzzati-Armentero et al.
FRONTIERS IN NEUROLOGY (2019)
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity
Liudmila Mus et al.
NEUROBIOLOGY OF DISEASE (2019)
Glucocerebrosidase mutations and phenoconversion of REM sleep behavior disorder to parkinsonism and dementia
Lucy Honeycutt et al.
PARKINSONISM & RELATED DISORDERS (2019)
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile
Stefanie Lerche et al.
MOVEMENT DISORDERS (2019)
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (vol 9, 7013, 2019)
Arvid Rongve et al.
SCIENTIFIC REPORTS (2019)
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine
Fabio Blandini et al.
MOVEMENT DISORDERS (2019)
Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION
Melissa Leija-Salazar et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset
Kimberley J. Billingsley et al.
NPJ PARKINSONS DISEASE (2019)
Lysosomal storage disorder gene variants in multiple system atrophy
Lasse Pihlstrom et al.
BRAIN (2018)
GBA-Associated Parkinson's Disease and Other Synucleinopathies
Ziv Gan-Or et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
The role of glucocerebrosidase in Parkinson disease pathogenesis
Matthew E. Gegg et al.
FEBS JOURNAL (2018)
Parkinson's Disease: Patients' Knowledge, Attitudes, and Interest in Genetic Counseling
Kristin A. Maloney et al.
JOURNAL OF GENETIC COUNSELING (2018)
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
Rita Guerreiro et al.
LANCET NEUROLOGY (2018)
A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients
Hong Jin et al.
NEUROSCIENCE LETTERS (2018)
Glucocerebrosidase gene variants are accumulated in idiopathic REM sleep behavior disorder
Ana Gamez-Valero et al.
PARKINSONISM & RELATED DISORDERS (2018)
GBA1 deficiency negatively affects physiological alpha-synuclein tetramers and related multimers
Sangjune Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
\The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients
Silvia Cerri et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes
Rafael Franco et al.
FRONTIERS IN NEUROANATOMY (2018)
The NAD plus Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease
David C. Schoendorf et al.
CELL REPORTS (2018)
Blood Lysosphingolipids Accumulation in Patients With Parkinson's Disease With Glucocerebrosidase 1 Mutations
Sofya Pchelina et al.
MOVEMENT DISORDERS (2018)
Finding useful biomarkers for Parkinson's disease
Alice S. Chen-Plotkin et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease
Farzaneh Atashrazm et al.
SCIENTIFIC REPORTS (2018)
PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis
Hui-Min Xu et al.
MOLECULAR NEUROBIOLOGY (2017)
Insights into the structural biology of Gaucher disease
Laura Smith et al.
EXPERIMENTAL NEUROLOGY (2017)
GBA Analysis in Next-Generation Era Pitfalls, Challenges, and Possible Solutions
Stefania Zampieri et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
Nahid Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2017)
AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy
Giuseppe Morabito et al.
MOLECULAR THERAPY (2017)
Cerebrospinal Fluid β-Glucocerebrosidase Activity Is Reduced in Parkinson's Disease Patients
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims et al.
NATURE GENETICS (2017)
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
Elma Aflaki et al.
NEURON (2017)
Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease
S. Pchelina et al.
NEUROSCIENCE LETTERS (2017)
A dose effect of mutations in the GBA gene on Parkinson's disease phenotype
Avner Thaler et al.
PARKINSONISM & RELATED DISORDERS (2017)
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
Thomas R. Barber et al.
SLEEP (2017)
GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort
Vanessa Lythe et al.
JOURNAL OF PARKINSONS DISEASE (2017)
A Human Neural Crest Stem Cell-Derived Dopaminergic Neuronal Model Recapitulates Biochemical Abnormalities in GBA1 Mutation Carriers
Shi-Yu Yang et al.
STEM CELL REPORTS (2017)
Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
Thomas R. Barber et al.
SLEEP (2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Laurie A. Robak et al.
BRAIN (2017)
Frequency of GBA Variants in Autopsy-proven Multiple System Atrophy
Miriam Sklerov et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates
Dale L. Bodian et al.
GENETICS IN MEDICINE (2016)
Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment
Carmen Gasca-Salas et al.
HUMAN BRAIN MAPPING (2016)
Ambroxol effects in glucocerebrosidase and -synuclein transgenic mice
Anna Migdalska-Richards et al.
ANNALS OF NEUROLOGY (2016)
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Ganqiang Liu et al.
ANNALS OF NEUROLOGY (2016)
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters
Roberto Cilia et al.
ANNALS OF NEUROLOGY (2016)
Navigating highly homologous genes in a molecular diagnostic setting: a resource for clinical next-generation sequencing
Diana Mandelker et al.
GENETICS IN MEDICINE (2016)
Glycosylation is crucial for a proper catalytic site organization in human glucocerebrosidase
Laercio Pol-Fachin et al.
GLYCOCONJUGATE JOURNAL (2016)
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
Joana Magalhaes et al.
HUMAN MOLECULAR GENETICS (2016)
The relationship between glucocerebrosidase mutations and Parkinson disease
Anna Migdalska-Richards et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons
Joseph R. Mazzulli et al.
JOURNAL OF NEUROSCIENCE (2016)
GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies
Ana Gamez-Valero et al.
MOVEMENT DISORDERS (2016)
Coming of age: ten years of next-generation sequencing technologies
Sara Goodwin et al.
NATURE REVIEWS GENETICS (2016)
Mitochondrial dysfunction associated with glucocerebrosidase deficiency
Matthew E. Gegg et al.
NEUROBIOLOGY OF DISEASE (2016)
Leukocyte glucocerebrosidase and β-hexosaminidase activity in sporadic and genetic Parkinson disease
Han-Joon Kim et al.
PARKINSONISM & RELATED DISORDERS (2016)
GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease
Silvia Jesus et al.
PLOS ONE (2016)
High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews
Tamara Shiner et al.
JAMA NEUROLOGY (2016)
ER Stress and Autophagic Per turbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S LEParkinson's iPSC-Derived Dopamine Neurons
Hugo J. R. Fernandes et al.
STEM CELL REPORTS (2016)
Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
Alvaro Sanchez-Martinez et al.
SCIENTIFIC REPORTS (2016)
Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease
Gian D. Pal et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2016)
Understanding the natural history of Gaucher disease
Pramod K. Mistry et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice
Emily M. Rocha et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations
Roy N. Alcalay et al.
BRAIN (2015)
Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death
Marcus Keatinge et al.
HUMAN MOLECULAR GENETICS (2015)
Glucocerebrosidase and Parkinson disease: Recent advances
Anthony H. V. Schapira
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies
Davide Chiasserini et al.
MOLECULAR NEURODEGENERATION (2015)
No evidence for substrate accumulation in Parkinson brains with GBA mutations
Matthew E. Gegg et al.
MOVEMENT DISORDERS (2015)
Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease
Tomoko Oeda et al.
NEUROBIOLOGY OF AGING (2015)
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
Giulia Ambrosi et al.
NEUROBIOLOGY OF DISEASE (2015)
Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons
Emily M. Rocha et al.
NEUROBIOLOGY OF DISEASE (2015)
Differential effects of severe vs mild GBA mutations on Parkinson disease
Ziv Gan-Or et al.
NEUROLOGY (2015)
Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease
Mario de la Mata et al.
SCIENTIFIC REPORTS (2015)
Evolution of Prodromal Clinical Markers of Parkinson Disease in a GBA Mutation-Positive Cohort
Michelle Beavan et al.
JAMA NEUROLOGY (2015)
Interest in Genetic Testing in Ashkenazi Jewish Parkinson's Disease Patients and Their Unaffected Relatives
Manisha Gupte et al.
JOURNAL OF GENETIC COUNSELING (2015)
GBA-Associated Parkinson's Disease: Reduced Survival and More Rapid Progression in a Prospective Longitudinal Study
Kathrin Brockmann et al.
MOVEMENT DISORDERS (2015)
Gene-Wise Association of Variants in Four Lysosomal Storage Disorder Genes in Neuropathologically Confirmed Lewy Body Disease
Lorraine N. Clark et al.
PLOS ONE (2015)
Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation (vol 47, e153, 2015)
Eun-Jin Bae et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Variants associated with Gaucher disease in multiple system atrophy
Jun Mitsui et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder
Ziv Gan-Or et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Progressive decline of glucocerebrosidase in aging and Parkinson's disease
Emily M. Rocha et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
An Overview of Autophagy: Morphology, Mechanism, and Regulation
Katherine R. Parzych et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
Alisdair McNeill et al.
BRAIN (2014)
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice
You-hai Xu et al.
HUMAN MOLECULAR GENETICS (2014)
Knowledge of and Interest in Genetic Results Among Parkinson Disease Patients and Caregivers
Karina Sakanaka et al.
JOURNAL OF GENETIC COUNSELING (2014)
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease
Benjamin R. Smith et al.
JOURNAL OF PATHOLOGY (2014)
Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
Homozygous TREM2 mutation in a family with atypical frontotemporal dementia
Isabelle Le Ber et al.
NEUROBIOLOGY OF AGING (2014)
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia
Agustin Ruiz et al.
NEUROBIOLOGY OF AGING (2014)
A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
Franziska Richter et al.
NEUROTHERAPEUTICS (2014)
Glucocerebrosidase mutations in primary parkinsonism
Rosanna Asselta et al.
PARKINSONISM & RELATED DISORDERS (2014)
Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
Emanuele Persichetti et al.
PLOS ONE (2014)
Glucocerebrosidase Gene Mutations Associated with Parkinson's Disease: A Meta-Analysis in a Chinese population
Jia Chen et al.
PLOS ONE (2014)
iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis
David C. Schoendorf et al.
NATURE COMMUNICATIONS (2014)
Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein
Eun-Jin Bae et al.
NATURE COMMUNICATIONS (2014)
Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease and GBA Heterozygotes
Roy N. Alcalay et al.
JAMA NEUROLOGY (2014)
Glucocerebrosidase mutations and the pathogenesis of Parkinson disease
Michelle S. Beavan et al.
ANNALS OF MEDICINE (2013)
Phenotype in patients with Gaucher disease and Parkinson disease
Eli Ben Chetrit et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
Inna Bendikov-Bar et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice
Zhuo Luan et al.
BRAIN & DEVELOPMENT (2013)
Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease-Links to Parkinson's Disease
Laura D. Osellame et al.
CELL METABOLISM (2013)
No association of GBA mutations and multiple system atrophy
K. Srulijes et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling
Huma Q. Rana et al.
GENETICS IN MEDICINE (2013)
Gender differences in Parkinson's disease: focus on plasma alpha-synuclein
Giovanni Caranci et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage
Michael W. J. Cleeter et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease
M. J. Barrett et al.
PARKINSONISM & RELATED DISORDERS (2013)
Prodromal Parkinson's disease – Using REM sleep behavior disorder as a window
Ronald B. Postuma
PARKINSONISM & RELATED DISORDERS (2013)
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
Michelle M. Mielke et al.
PLOS ONE (2013)
Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
Michael A. Nalls et al.
JAMA NEUROLOGY (2013)
Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage
Katherine R. Smith et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Matthew E. Gegg et al.
ANNALS OF NEUROLOGY (2012)
The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow
Ozlem Goker-Alpan et al.
BRAIN (2012)
Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease
Einat B. Vitner et al.
BRAIN (2012)
Discovery, Structure-Activity Relationship, and Biological Evaluation of Noninhibitory Small Molecule Chaperones of Glucocerebrosidase
Samarjit Patnaik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease
Pablo Martinez-Martin et al.
JOURNAL OF NEUROLOGY (2012)
A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers
Alisdair McNeill et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
The link between the GBA gene and parkinsonism
Ellen Sidransky et al.
LANCET NEUROLOGY (2012)
The role of saposin C in Gaucher disease
Rafael J. Tamargo et al.
MOLECULAR GENETICS AND METABOLISM (2012)
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
Debby Tsuang et al.
NEUROLOGY (2012)
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
M. Anheim et al.
NEUROLOGY (2012)
Neuropathology underlying clinical variability in patients with synucleinopathies
Glenda M. Halliday et al.
ACTA NEUROPATHOLOGICA (2011)
Acid β-Glucosidase Mutants Linked to Gaucher Disease, Parkinson Disease, and Lewy Body Dementia Alter α-Synuclein Processing
Valerie Cullen et al.
ANNALS OF NEUROLOGY (2011)
The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry
Barry Rosenbloom et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
Parkinsonism Associated with Glucocerebrosidase Mutation
Mun-Kyung Sunwoo et al.
JOURNAL OF CLINICAL NEUROLOGY (2011)
The enigma of the E326K mutation in acid β-glucocerebrosidase
Mia Horowitz et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models
Y. H. Xu et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease
Stefan P. Schmid et al.
MOVEMENT DISORDERS (2011)
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Guenter U. Hoeglinger et al.
NATURE GENETICS (2011)
Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data
Gregory M. Cooper et al.
NATURE REVIEWS GENETICS (2011)
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
Lydia Alvarez-Erviti et al.
NEUROBIOLOGY OF DISEASE (2011)
GBA-associated PD presents with nonmotor characteristics
K. Brockmann et al.
NEUROLOGY (2011)
Glucocerebrosidase mutations in diffuse Lewy body disease
Kenya Nishioka et al.
PARKINSONISM & RELATED DISORDERS (2011)
CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Towards Unveiling the Genetics of Neurodegenerative Diseases
Christina M. Lill et al.
SEMINARS IN NEUROLOGY (2011)
Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders
Ozlem Goker-Alpan et al.
ACTA NEUROPATHOLOGICA (2010)
Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
Lydia Alvarez-Erviti et al.
ARCHIVES OF NEUROLOGY (2010)
Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants
Olle Nilsson et al.
CLINICAL GENETICS (2010)
Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease
Idit Ron et al.
HUMAN MOLECULAR GENETICS (2010)
The risk of Parkinson's disease in type 1 Gaucher disease
Gilberto Bultron et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Pathogenic Lysosomal Depletion in Parkinson's Disease
Benjamin Dehay et al.
JOURNAL OF NEUROSCIENCE (2010)
Functional Brain Imaging in Glucocerebrosidase Mutation Carriers With and Without Parkinsonism
Satoshi Kono et al.
MOVEMENT DISORDERS (2010)
Association of Glucocerebrosidase Mutations With Dementia With Lewy Bodies
Lorraine N. Clark et al.
ARCHIVES OF NEUROLOGY (2009)
Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study
G. Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal
Jose Bras et al.
NEUROBIOLOGY OF AGING (2009)
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies
L. Parnetti et al.
NEUROBIOLOGY OF DISEASE (2009)
GLUCOCEREBROSIDASE MUTATIONS IN 108 NEUROPATHOLOGICALLY CONFIRMED CASES OF MULTIPLE SYSTEM ATROPHY
B. Segarane et al.
NEUROLOGY (2009)
Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism
Amy B. Manning-Bog et al.
NEUROTOXICOLOGY (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Acid β-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy
Yaacov Kacher et al.
BIOLOGICAL CHEMISTRY (2008)
Gaucher disease:: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Kathleen S. Hruska et al.
HUMAN MUTATION (2008)
Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski
LANCET (2008)
A novel deletion in progranulin gene is associated with FTDP-17 and CBS
Luisa Benussi et al.
NEUROBIOLOGY OF AGING (2008)
Progranulin genetic variability contributes to amyotrophic lateral sclerosis
K. Sleegers et al.
NEUROLOGY (2008)
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Z. Gan-Or et al.
NEUROLOGY (2008)
Murine models of acute neuronopathic Gaucher disease
Ida Berglin Enquist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Three classes of gluclocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease
Wei Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gender differences in Parkinson's disease
Charlotte A. Haaxma et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
Chiara Balducci et al.
MOVEMENT DISORDERS (2007)
Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients
Eng-King Tan et al.
ARCHIVES OF NEUROLOGY (2007)
Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain
Pilar Alfonso et al.
JOURNAL OF HUMAN GENETICS (2007)
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
O. Goker-Alpan et al.
NEUROLOGY (2006)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Mutation analysis of Gaucher disease patients in Taiwan:: High prevalence of the RecNciI and L444P mutations
Lei Wan et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity
I Ron et al.
HUMAN MOLECULAR GENETICS (2005)
Divergent phenotypes in Gaucher disease implicate the role of modifiers
O Goker-Alpan et al.
JOURNAL OF MEDICAL GENETICS (2005)
Aberrant phosphorylation of α-synuclein in human Niemann-Pick type C1 disease
Y Saito et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Gaucher disease: complexity in a simple disorder
E Sidransky
MOLECULAR GENETICS AND METABOLISM (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
Lipid rafts mediate the synaptic localization of α-synuclein
DL Fortin et al.
JOURNAL OF NEUROSCIENCE (2004)
Parkinsonism among Gaucher disease carriers
O Goker-Alpan et al.
JOURNAL OF MEDICAL GENETICS (2004)
Gaucher's disease with Parkinson's disease - Clinical and pathological aspects
B Bembi et al.
NEUROLOGY (2003)
X-ray structure of human acid-β-glucosidase, the defective enzyme in Gaucher disease
H Dvir et al.
EMBO REPORTS (2003)
Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors
HJ Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Gaucher disease and parkinsonism: A phenotypic and genotypic characterization
N Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease
V Koprivica et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Type 2 Gaucher disease: the collodion baby phenotype revisited
DL Stone et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2000)
Share Paper
